Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (511-520 of 532) with videos related to

Pageof 54
Sort By:
Journal of Medicinal Chemistry|December 5, 2008
Probes for narcotic receptor mediated phenomena. 37. Synthesis and opioid binding affinity of the final pair of oxide-bridged phenylmorphans, the ortho- and para-b-isomers and their N-phenethyl analogues, and the synthesis of the N-phenethyl analogues of the ortho- and para-d-isomersMuneaki Kurimura, Hehua Liu, Agnieszka Sulima, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2011
A SOCS-1 promoter variant is associated with total serum IgE levelsJustin Mostecki, Suzanne L Cassel, Walter T Klimecki, et al.
Brain Research. Molecular Brain Research|December 3, 1999
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpressionD M Donovan, L L Miner, M P Perry, et al.
Journal of Medicinal Chemistry|August 10, 2001
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activityJ B Thomas, R N Atkinson, R B Rothman, et al.
European Journal of Immunology|December 7, 2011
Tim-1 regulates Th2 responses in an airway hypersensitivity modelMiranda L Curtiss, Jacob V Gorman, Thomas R Businga, et al.
Journal of Medicinal Chemistry|December 19, 1998
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidineJ B Thomas, M J Fall, J B Cooper, et al.
Nature Genetics|February 9, 2010
Identification of DOK genes as lung tumor suppressorsAlice H Berger, Masaru Niki, Alessandro Morotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
NFIL3 is a regulator of IL-12 p40 in macrophages and mucosal immunityTaku Kobayashi, Katsuyoshi Matsuoka, Shehzad Z Sheikh, et al.
Synapse (New York, N.Y.)|December 3, 2009
Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptorElliott J Sally, Heng Xu, Christina M Dersch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2014
NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitisTaku Kobayashi, Erin C Steinbach, Steven M Russo, et al.
Pageof 54

Showing results (511-520 of 532) with videos related to

Sort By:
Pageof 54
Journal of Medicinal Chemistry|December 5, 2008
Probes for narcotic receptor mediated phenomena. 37. Synthesis and opioid binding affinity of the final pair of oxide-bridged phenylmorphans, the ortho- and para-b-isomers and their N-phenethyl analogues, and the synthesis of the N-phenethyl analogues of the ortho- and para-d-isomersMuneaki Kurimura, Hehua Liu, Agnieszka Sulima, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2011
A SOCS-1 promoter variant is associated with total serum IgE levelsJustin Mostecki, Suzanne L Cassel, Walter T Klimecki, et al.
Brain Research. Molecular Brain Research|December 3, 1999
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpressionD M Donovan, L L Miner, M P Perry, et al.
Journal of Medicinal Chemistry|August 10, 2001
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activityJ B Thomas, R N Atkinson, R B Rothman, et al.
European Journal of Immunology|December 7, 2011
Tim-1 regulates Th2 responses in an airway hypersensitivity modelMiranda L Curtiss, Jacob V Gorman, Thomas R Businga, et al.
Journal of Medicinal Chemistry|December 19, 1998
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidineJ B Thomas, M J Fall, J B Cooper, et al.
Nature Genetics|February 9, 2010
Identification of DOK genes as lung tumor suppressorsAlice H Berger, Masaru Niki, Alessandro Morotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
NFIL3 is a regulator of IL-12 p40 in macrophages and mucosal immunityTaku Kobayashi, Katsuyoshi Matsuoka, Shehzad Z Sheikh, et al.
Synapse (New York, N.Y.)|December 3, 2009
Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptorElliott J Sally, Heng Xu, Christina M Dersch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2014
NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitisTaku Kobayashi, Erin C Steinbach, Steven M Russo, et al.
Pageof 54